Form 4: Blueprint Medicines CFO Sells Shares to Cover Tax Obligations

Michael Landsittel, CFO of Blueprint Medicines Corp, sold 5,003 shares of common stock on March 7, 2024, at a price of $90.69 to cover tax withholding obligations.

Summary

• On March 7, 2024, Michael Landsittel, the Chief Financial Officer of Blueprint Medicines Corp, sold 5,003 shares of the company's common stock.
• The sale was executed at a price of $90.69 per share.
• The transaction was conducted to cover tax withholding obligations related to the vesting of restricted stock units.
• Following the transaction, Landsittel directly owns 56,020 shares of Blueprint Medicines Corp.
• A Limited Power of Attorney was executed on January 31, 2023, granting certain individuals the authority to act on behalf of Michael Landsittel in matters related to securities filings.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the transaction is a routine sale to cover tax obligations and doesn't necessarily reflect a change in the executive's confidence in the company.

Industry Context

Executive stock sales are a common occurrence, often related to compensation and tax planning. Monitoring these transactions can provide insights into management's perspective on the company's value, although sales to cover taxes are generally less informative.

Stakeholder Impact

• The stock sale may have a minor impact on shareholders due to the small volume of shares sold.

Key Dates